Expression of CD16, CD18 and CD56 in tributyltin-exposed human natural killer cells.
Tributyltin (TBT) was produced in large quantities for use in wood preservation, marine antifouling paints, disinfection of circulating industrial cooling waters and slime control in paper mills. TBT is found in dairy products, meat and fish. We and others have shown that there are measurable levels of TBT in human blood. BTs appear to increase the risk of cancer and viral infections in exposed individuals. In previous studies, we demonstrated that the NK-cytotoxic function of lymphocytes was greatly diminished after a 1-h exposure to 300 nM TBT or a 24-h exposure to 200 nM TBT. Inhibition induced by a 1-h exposure to 300 nM TBT continues even after removal of the compound. There is also decreased ability of NK cells to bind to tumor target cells when they have been exposed to 200 nM TBT for 24 h. This loss of binding function is not seen when NK cells are exposed to 300 nM TBT for 1 h. However, NK cells exposed to 300 nM TBT for 1 h and then incubated in TBT-free media for 24, 48 or 96 h, show a significant loss of tumor-binding function by 96 h. The effects of TBT on cell surface molecules that are crucial to NK cell function is investigated. The data indicate there is a loss of expression of CD16 and CD56 on NK cells exposed to 200 nM TBT for 24 h. There is no decrease in expression of any of the markers studied when NK cells are exposed to 300 nM TBT for 1 h, consistent with the fact that a 1-h exposure has no effect on the ability of NK cells to bind to tumor targets. However, when NK cells are exposed to 300 nM TBT followed by 24, 48 or 96 h incubations in TBT-free media, there is a significant loss of CD16 and CD18 expression after 24 h and of CD16 and CD56 expression after 48 and 96 h.
Whalen
Margaret M
MM
Department of Chemistry, Tennessee State University, 3500 John A. Merritt Blvd., Nashville, TN 37209, USA. mwhalen@picard.tnstate.edu
Ghazi
Sabah
S
Loganathan
Bommanna G
BG
Hatcher
Frank
F
D000293:Adolescent; D000368:Aged; D018821:CD18 Antigens / Q000096:biosynthesis*; D019002:CD56 Antigen / Q000096:biosynthesis*; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004785:Environmental Pollutants / Q000633:toxicity*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D017452:Receptors, IgG / Q000096:biosynthesis*; D013997:Time Factors; D014220:Trialkyltin Compounds / Q000633:toxicity*
D018821:CD18 Antigens; D019002:CD56 Antigen; D004785:Environmental Pollutants; D017452:Receptors, IgG; D014220:Trialkyltin Compounds; C011559:tributyltin